Cargando…

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy

PURPOSE: Gonadotropin-releasing hormone (GnRH) agonists have been used with adjuvant chemotherapy to protect ovarian function. However, there are no data on the actual pregnancy rates among young breast cancer patients receiving GnRH agonists and concurrent chemotherapy in Korea. METHODS: Among pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Isaac, Ryu, Jai Min, Paik, Hyun-June, Park, Sungmin, Bae, Soo Youn, Lee, Se Kyung, Yu, Jonghan, Kim, Seok Won, Nam, Seok Jin, Lee, Jeong Eon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Breast Cancer Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378584/ https://www.ncbi.nlm.nih.gov/pubmed/28382099 http://dx.doi.org/10.4048/jbc.2017.20.1.91

Ejemplares similares

Conditional disease-free survival among patients with breast cancer
por: Paik, Hyun-June, et al.
Publicado: (2017)

Adjuvant endocrine therapy alone in patients with node-positive, luminal A type breast cancer
por: Park, Sungmin, et al.
Publicado: (2017)

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy
por: Choi, Hee Jun, et al.
Publicado: (2023)

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study
por: Ryu, Jai Min, et al.
Publicado: (2017)

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry
por: You, Kiho, et al.
Publicado: (2017)

Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer
por: Kim, Jae-Myung, et al.
Publicado: (2018)

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer
por: Woo, Hye In, et al.
Publicado: (2017)

Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients
por: Choi, Rihwa, et al.
Publicado: (2018)

The role of gonadotropin-releasing hormone agonists in female fertility preservation
por: Lee, Jae Hoon, et al.
Publicado: (2021)

Prediction of Successful Ovarian Protection Using Gonadotropin-Releasing Hormone Agonists During Chemotherapy in Young Estrogen Receptor-Negative Breast Cancer Patients
por: Lee, Dong-Yun, et al.
Publicado: (2020)

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis
por: Choi, Hee Jun, et al.
Publicado: (2018)

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer
por: Choi, Hee Jun, et al.
Publicado: (2019)

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer
por: Park, Woong Ki, et al.
Publicado: (2023)

Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients
por: Kim, Jee Ah, et al.
Publicado: (2020)

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients
por: Bang, Yoon Ju, et al.
Publicado: (2022)

Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer
por: Kim, Isaac, et al.
Publicado: (2018)

Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
por: Hong, Yeon Hee, et al.
Publicado: (2022)

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay
por: Lee, Jun-Hee, et al.
Publicado: (2022)

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study
por: Choi, Hee Jun, et al.
Publicado: (2018)

Time Points for Gonadotropin-Releasing Hormone Stimulation Test Results in Korean Children
por: Choi, Rihwa, et al.
Publicado: (2021)

Luteal estradiol supplementation in gonadotropin-releasing hormone antagonist cycles for infertile patients in vitro fertilization
por: Kwon, Su-Kyoung, et al.
Publicado: (2013)

Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea
por: Rayzah, Musaed, et al.
Publicado: (2021)

Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence
por: Ryu, Jai Min, et al.
Publicado: (2020)

Adjuvant gonadotropin releasing hormone analog in gonadotoxic chemotherapy for preservation of fertility
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

The Effect of Combined Growth Hormone and a Gonadotropin-Releasing Hormone Agonist Therapy on Height in Korean 3-M Syndrome Siblings
por: Lee, In Kyung, et al.
Publicado: (2020)

Age at menarche and near final height after treatment with gonadotropin-releasing hormone agonist alone or combined with growth hormone in Korean girls with central precocious puberty
por: Gyon, YunHee, et al.
Publicado: (2015)

Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors
por: Shim, Sungkeun, et al.
Publicado: (2022)

Validation of the Clinical Treatment Score Post–Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea
por: Lee, Jun-Hee, et al.
Publicado: (2021)

Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis
por: Lee, Jun-Hee, et al.
Publicado: (2023)

A Case of Cyclic Vomiting Syndrome Responding to Gonadotropin-Releasing Hormone Analogue
por: Shin, Young Kook, et al.
Publicado: (2010)

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study
por: Choi, Hee Jun, et al.
Publicado: (2021)

Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery
por: Lee, Jun Hee, et al.
Publicado: (2015)

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy
por: Park, Jeong Hyun, et al.
Publicado: (2018)

Cessation of Gonadotropin-Releasing Hormone Antagonist on Triggering Day: An Alternative Method for Flexible Multiple-Dose Protocol
por: Chang, Hye Jin, et al.
Publicado: (2009)

Uterine fibroid shrinkage after short-term use of selective progesterone receptor modulator or gonadotropin-releasing hormone agonist
por: Lee, Min Jin, et al.
Publicado: (2017)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
por: Kim, Hye Ryun, et al.
Publicado: (2017)

Transient impact of paclitaxel on mouse fertility and protective effect of gonadotropin-releasing hormone agonist
por: Ma, Nieying, et al.
Publicado: (2020)

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
por: Woo, Jinsun, et al.
Publicado: (2021)

Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm
por: Alsharif, Emad, et al.
Publicado: (2019)

Scheduling cycles with gonadotropin-releasing hormone antagonist protocol in in vitro fertilization: Is there a scope in batch in vitro fertilization?
por: Gutgutia, Rohit, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qn811ht8a5u4pss9oujc3po0lk